UY25197A1 - Un procedimiento para mejorar la producción de 5r clavams - Google Patents
Un procedimiento para mejorar la producción de 5r clavamsInfo
- Publication number
- UY25197A1 UY25197A1 UY25197A UY25197A UY25197A1 UY 25197 A1 UY25197 A1 UY 25197A1 UY 25197 A UY25197 A UY 25197A UY 25197 A UY25197 A UY 25197A UY 25197 A1 UY25197 A1 UY 25197A1
- Authority
- UY
- Uruguay
- Prior art keywords
- clavam
- production
- clavulanic acid
- clavams
- amoxicillin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere a nuevos genes bacterianos y procedimiento para mejorar la fabricación de clavams, por ejemplo, ácido clavulánico útil como antibiótico. También proporciona nuevos organismos capaces de producir cantidades incrementadas de ácido clavulánico. Un proceso para mejorar la producción de 5R clavam en un microorganismo adecuado que comprende la manipulación de ADN que comprende uno o más genes específicos para la biosíntesis de 5R clavam en S. Clavuligerus que no es esencial para la biosíntesis de 5R clavam, y su inclusión en dicho microorganismo. Dicho proceso comprende la disrupción u otra manera de hacer defectuosas las regiones de ADN que flanquean a cas1. Se presenta un proceso en el que el 5S clavam es clavam-2-carboxilato y/o 2-hidroximetilclavam. Y un proceso para la preparación de una composición que comprende clavulnato de potasio y amoxicilina, comprendiendo dicho proceso la producción de ácido clavulánico y en adelante convertirlo en sal de potasio y la sal de potasio con amoxicilina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9702218.0A GB9702218D0 (en) | 1997-02-04 | 1997-02-04 | Novel product |
UY24874A UY24874A1 (es) | 1997-02-04 | 1998-02-03 | Nuevos compuestos |
Publications (1)
Publication Number | Publication Date |
---|---|
UY25197A1 true UY25197A1 (es) | 1998-11-27 |
Family
ID=10807030
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY24874A UY24874A1 (es) | 1997-02-04 | 1998-02-03 | Nuevos compuestos |
UY25197A UY25197A1 (es) | 1997-02-04 | 1998-09-30 | Un procedimiento para mejorar la producción de 5r clavams |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY24874A UY24874A1 (es) | 1997-02-04 | 1998-02-03 | Nuevos compuestos |
Country Status (32)
Country | Link |
---|---|
US (5) | US6936458B1 (es) |
EP (2) | EP1405913A3 (es) |
JP (2) | JP4227199B2 (es) |
KR (2) | KR100514964B1 (es) |
CN (2) | CN1192107C (es) |
AP (1) | AP1320A (es) |
AR (2) | AR011100A1 (es) |
AT (1) | ATE312926T1 (es) |
AU (1) | AU735782B2 (es) |
BG (1) | BG103704A (es) |
BR (1) | BR9807144A (es) |
CA (1) | CA2279207A1 (es) |
DE (1) | DE69832783T2 (es) |
DZ (1) | DZ2413A1 (es) |
EA (1) | EA003773B1 (es) |
ES (1) | ES2255149T3 (es) |
GB (1) | GB9702218D0 (es) |
HU (1) | HUP0001048A3 (es) |
ID (1) | ID22144A (es) |
IL (1) | IL131043A0 (es) |
MA (1) | MA24464A1 (es) |
MY (1) | MY140928A (es) |
NO (1) | NO993758D0 (es) |
NZ (1) | NZ336894A (es) |
OA (1) | OA11082A (es) |
PL (1) | PL334961A1 (es) |
SK (1) | SK105499A3 (es) |
TR (1) | TR199901862T2 (es) |
TW (2) | TW200307041A (es) |
UY (2) | UY24874A1 (es) |
WO (1) | WO1998033896A2 (es) |
ZA (1) | ZA98868B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001019959A1 (en) * | 1999-09-16 | 2001-03-22 | The Johns Hopkins University | Improvement of clavulanic acid production |
EP1228218A2 (en) * | 1999-10-22 | 2002-08-07 | Smithkline Beecham Plc | 5r clavam producing microorganisms with deleted lat and cvm genes |
GB0308696D0 (en) * | 2003-04-15 | 2003-05-21 | Glaxo Group Ltd | New process |
EP2589663A1 (en) | 2011-11-04 | 2013-05-08 | LEK Pharmaceuticals d.d. | Process for production of clavulanic acid |
CN107964522B (zh) * | 2018-01-04 | 2020-12-08 | 上海交通大学 | 海洋链霉菌dut11及其抗补体活性应用 |
CN114072493A (zh) | 2019-07-05 | 2022-02-18 | 葛兰素史密斯克莱知识产权(第2 号)有限公司 | 棒状链霉菌 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4110165A (en) * | 1974-04-20 | 1978-08-29 | Beecham Group Limited | Process for the production of clavulanic acid |
IT1059403B (it) * | 1975-02-07 | 1982-05-31 | Glaxo Lab Ltd | Procedimento per produrre acido clavulanico e suoi derivati nonche composizioni che lo contengono |
GB1585661A (en) | 1976-06-08 | 1981-03-11 | Glaxo Lab Ltd | Clavam derivatives |
JPS589679B2 (ja) | 1977-02-24 | 1983-02-22 | 武田薬品工業株式会社 | 抗生物質の製造法 |
US4202819A (en) | 1979-05-04 | 1980-05-13 | Hoffman-La Roche Inc. | 2-(3-Alanyl)clavam antibiotic |
GB8521516D0 (en) * | 1985-08-29 | 1985-10-02 | Beecham Group Plc | Compounds |
GB9020683D0 (en) | 1990-09-22 | 1990-11-07 | Univ Strathclyde | Isolation of dna |
CA2108113C (en) * | 1993-10-08 | 2006-12-05 | Susan E. Jensen | Dna sequence encoding enzymes of clavulanic acid biosynthesis |
-
1997
- 1997-02-04 GB GBGB9702218.0A patent/GB9702218D0/en active Pending
-
1998
- 1998-01-27 MY MYPI98000390A patent/MY140928A/en unknown
- 1998-02-02 KR KR10-1999-7006973A patent/KR100514964B1/ko not_active IP Right Cessation
- 1998-02-02 CN CNB988037475A patent/CN1192107C/zh not_active Expired - Lifetime
- 1998-02-02 DE DE69832783T patent/DE69832783T2/de not_active Expired - Lifetime
- 1998-02-02 AR ARP980100451A patent/AR011100A1/es unknown
- 1998-02-02 TR TR1999/01862T patent/TR199901862T2/xx unknown
- 1998-02-02 MA MA24953A patent/MA24464A1/fr unknown
- 1998-02-02 CN CNA2004100105601A patent/CN1696301A/zh active Pending
- 1998-02-02 SK SK1054-99A patent/SK105499A3/sk unknown
- 1998-02-02 ES ES98906924T patent/ES2255149T3/es not_active Expired - Lifetime
- 1998-02-02 JP JP53256398A patent/JP4227199B2/ja not_active Expired - Lifetime
- 1998-02-02 KR KR1020057007954A patent/KR20050053794A/ko not_active Application Discontinuation
- 1998-02-02 HU HU0001048A patent/HUP0001048A3/hu unknown
- 1998-02-02 EP EP03078351A patent/EP1405913A3/en not_active Withdrawn
- 1998-02-02 AT AT98906924T patent/ATE312926T1/de not_active IP Right Cessation
- 1998-02-02 PL PL98334961A patent/PL334961A1/xx unknown
- 1998-02-02 CA CA002279207A patent/CA2279207A1/en not_active Abandoned
- 1998-02-02 WO PCT/EP1998/000644 patent/WO1998033896A2/en not_active Application Discontinuation
- 1998-02-02 NZ NZ336894A patent/NZ336894A/en unknown
- 1998-02-02 AP APAP/P/1999/001614A patent/AP1320A/en active
- 1998-02-02 EA EA199900718A patent/EA003773B1/ru not_active IP Right Cessation
- 1998-02-02 EP EP98906924A patent/EP0970198B1/en not_active Expired - Lifetime
- 1998-02-02 IL IL13104398A patent/IL131043A0/xx unknown
- 1998-02-02 ID IDW990801A patent/ID22144A/id unknown
- 1998-02-02 AU AU62953/98A patent/AU735782B2/en not_active Ceased
- 1998-02-02 BR BR9807144-0A patent/BR9807144A/pt not_active IP Right Cessation
- 1998-02-03 ZA ZA9800868A patent/ZA98868B/xx unknown
- 1998-02-03 UY UY24874A patent/UY24874A1/es not_active Application Discontinuation
- 1998-02-04 DZ DZ980023A patent/DZ2413A1/xx active
- 1998-05-12 TW TW092119091A patent/TW200307041A/zh unknown
- 1998-05-12 TW TW087107252A patent/TW589377B/zh not_active IP Right Cessation
- 1998-09-30 UY UY25197A patent/UY25197A1/es not_active IP Right Cessation
-
1999
- 1999-03-04 AR ARP990100913A patent/AR018304A2/es unknown
- 1999-07-09 US US09/350,702 patent/US6936458B1/en not_active Expired - Lifetime
- 1999-08-03 NO NO993758A patent/NO993758D0/no not_active Application Discontinuation
- 1999-08-04 OA OA9900170A patent/OA11082A/en unknown
- 1999-09-01 BG BG103704A patent/BG103704A/xx unknown
-
2002
- 2002-02-08 US US10/071,338 patent/US20030022321A1/en not_active Abandoned
- 2002-11-07 US US10/214,519 patent/US20030166175A1/en not_active Abandoned
- 2002-11-07 US US10/289,980 patent/US20030124690A1/en not_active Abandoned
-
2004
- 2004-10-08 US US10/961,636 patent/US7344869B2/en not_active Expired - Fee Related
-
2008
- 2008-10-01 JP JP2008256485A patent/JP5042186B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002066667A8 (en) | Glucosamine and method of making glucosamine from microbial biomass | |
AU5102899A (en) | Process and materials for production of glucosamine | |
DE60029091D1 (de) | Verfahren zur herstellung von diphtheria toxin | |
AU679978B2 (en) | Enzymatic hydrolysis methods for the preparation of C-10 andC-13 hydroxyl-bearing taxanes, enzymatic esterification method for the preparation of C-10 acyloxy-bearing taxanes, and use thereof in the preparation of C-13 acyloxy-bearing taxanes | |
UY25197A1 (es) | Un procedimiento para mejorar la producción de 5r clavams | |
ATE92532T1 (de) | Verfahren zur herstellung von polysacchariden. | |
MY136899A (en) | Method for producing copolyester | |
PT711349E (pt) | Genes que codificam para o complexo desidrogenase de acido alfa-cetonico de cadeia ramificada a partir de streptomyces avermitilis | |
ATE486967T1 (de) | Herstellung von thiamin durch fermentation | |
DE3884741T2 (de) | Mikrobiologisches Verfahren zur Herstellung von UK-61.689 und Mikroorganismen zur Verwendung darin. | |
Hosseini Khayat et al. | Production of clavulanic acid by Streptomyces clavuligerus in batch cultures with using wheat bran as the source of carbon | |
GB9424950D0 (en) | Novel process | |
EP1229127B1 (de) | Verfahren zur enzymatischen Herstellung von enantiomerenreinen 1,3-Dioxolan-4-on- und 1,3-Oxathiolan-5-on-Derivaten | |
ATE283362T1 (de) | Verfahren zur erhöhung der produktion von clavam- antibiotika | |
Briant | The Effect of Phosphate in the Production of Tetracycline by the Fermentation of Streptomyces aureofaciens | |
JPS5537136A (en) | Preparation of cephalosporin antibiotic | |
WO1998002556A3 (en) | Screening for and use of an esterase for a stereospecific resolution | |
ATE279527T1 (de) | Verfahren zur herstellung von l-2- aminoadipinsäure | |
RU94031719A (ru) | Способ получения биомассы микроорганизмов | |
Mori et al. | Preparative Bioorganic Chemistry, XI Preparation of the Enantiomers of Paraconic Acid Employing Lipase‐Mediated Asymmetric Hydrolysis of Prochiral Diacetates as the Key Step | |
KR850007084A (ko) | 항생물질의 제조방법 | |
JPH0556777A (ja) | ビタミンb▲12▼要求性株の培養方法およびこれにより得られたビタミンb▲12▼要求性株 | |
ES2187219B1 (es) | Mejora de cepas de streptomyces mediante la utilizacion de genes biosinteticos de acido clavulanico. | |
BRPI9816369C1 (pt) | processo para produção de ácido araquidônico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
VENC | Patent expired |
Effective date: 20180930 |